Cancer Research UK, Cytovation, and the Norwegian Cancer Society collaborate to advance treatment for adrenocortical ...

Cabozantinib s-malate is under clinical development by Ipsen and currently in Phase II for Adrenocortical Carcinoma (Adrenal Cortex Cancer). According to GlobalData, Phase II drugs for Adrenocortical ...

[15] An ongoing, multicenter study -- the First International Randomized Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment [18] (FIRM-ACT; www.firm-act.org) -- will ...

Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Adrenocortical Carcinoma (Adrenal Cortex Cancer). According to GlobalData, Phase II drugs for ...

We have a deep understanding of how to evaluate your condition and how select and combine treatments to get the best possible results — even for rare cancers that many doctors in the community never ...

Collaboration to take Cytovation's synthetic peptide, CY-101, into a Phase 2 trial for patients with adrenocortical carcinoma <li /> Ca ...

Nat Clin Pract Endocrinol Metab. 2007;3(2):191-195. According to early studies, high glucose uptake on FDG-PET scans suggests malignancy; in addition, these scans could be helpful to detect ...

which was initially misidentified as adrenocortical carcinoma due to its size. This case illustrates the diagnostic difficulties associated with adrenal schwannomas and the importance of ...

provided by the Sidney Kimmel Comprehensive Cancer Center. Results: Results are available in a week. Please contact your doctor if you are not called about the result. Adrenocorticotropic Hormone ...